No Evidence of Post-finasteride Syndrome in 267,983 Person-years Follow-up in the Prostate Cancer Prevention Trial
Authors:
- Cathee TillCTCathee Till
- Catherine M. TangenCTCatherine M. Tangen
- Phyllis GoodmanPGPhyllis Goodman
- Joseph M. UngerJUJoseph M. Unger
- Ian M. ThompsonITIan M. Thompson
Abstract
No abstract availableFunding Information
- National Institutes of Health
- Hope Foundation
- National Cancer Institute (CA182883)
- National Cancer Institute (CA189974)
This publication has 8 references indexed in Scilit:
- Finasteride Use: Evaluation of Depression and Suicide RiskJournal of Cosmetic Dermatology, 2025
- Atypical post-finasteride syndrome: A pharmacological riddleIndian Journal of Pharmacology, 2016
- Finasteride Reduces the Risk of Incident Clinical Benign Prostatic HyperplasiaEuropean Urology, 2012
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic HyperplasiaNew England Journal of Medicine, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972